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Italy is considered a low incidence country for tick-borne 
encephalitis (TBE) in Europe1. Areas at higher risk for TBE in 
Italy are geographically clustered in the forested and 
mountainous regions and provinces in the north east part of 
the country, as suggested by TBE case series published over 
the last decade2-5. A national enhanced surveillance system 
for TBE has been established since 20176. Before this, 
information on the occurrence of TBE cases at national level 
in Italy was lacking. Both incidence rates and the 
geographical distribution of the disease were mostly 
inferred from endemic areas where surveillance was 
already in place, ad hoc studies and international 
literature1. 
TBE has been recorded in Italy since 1967, with foci of 
infection in north east (Trento, Belluno and Gorizia) and 
central Italy (Florence and Latina) provinces7-10. TBE 
presence in central Italy has not been confirmed by further 
studies on ticks and serosurveys conducted afterwards11-12, 
suggesting the extinction of these small endemic foci. 
Serological investigations of people at risk such as forestry 
rangers, hunters and mushrooms collectors, have been 
performed in order to get information on TBE virus (TBEv) 
circulation in the pre-alpine and alpine regions reporting 
seroprevalence values of 0.6%, 1.07% and 3.2% in Friuli-
Venezia Giulia13, Trento province14 and Turin province15, 
respectively. Interestingly, Turin province has never 
reported human cases of TBEV infection, so far.  
A retrospective study conducted in 2015 in the north east 
regions, allowed the identification of 367 cases (0.38 per 
100,000 inhabitants) during the period from 2000 to 20133. 
TBE cases were mainly males (70%), and around 70% of 
them were between 30 and 70 years of age. A significant 
increase in the annual incidence rate (IR) was observed 
during the study period, from 0.18 per 100,000 in the year 
2000 up to 0.59 per 100,000 in 2013 (incidence rate ratio 
[IRR]=1.05 per 1 calendar year increase, 95% confidence 
interval [CI]: 1.02–1.08, P>0.01). The majority of identified 
TBE cases occurred between April and October, consistent 
with the seasonality of tick activity. Areas with IR greater 
than 10 per 100,000 appear to be concentrated in 3 main 
foci: 1 in the Autonomous Province of Trento (IR=41.6), 1 in 
the Belluno Alps in Veneto (IR=35.9), and the third at the 
extreme north east section of Friuli-Venezia Giulia (IR=42.6)
3. According to this study, the risk of TBE is associated with 
altitude, with the highest values found for municipalities 
between 400 and 600 m a.s.l., and the IR falling along with 
municipality altitude decrease or increase. Of note, the IR 
for municipalities with a mean altitude >800 m a.s.l. 
appears to be 5 times higher than for municipalities with a 
mean altitude <200 m a.s.l.3. 
In 2018, the recently established national TBE surveillance 
system recorded a total of 40 confirmed cases of neuro-
invasive TBEv infection in four north eastern Italian regions 
and provinces: Trento, Bolzano, Friuli-Venezia Giulia and 
Veneto. Incidence ranged from 0.16 per 100,000 in Friuli-
Venezia Giulia to 1.48 in the Trento province where, 
regional surveillance has detected increases in the annual 
number of TBE cases, with transmission spreading outside 
the historically recognised foci5,16.  
Vaccination for TBE is currently recommended in Italy 
among residents and professionally exposed groups, in 
particular in rural endemic areas17. In affected regions and 
provinces, TBE is offered free of charge to risk groups and 
the resident population since 2013 in Friuli Venezia Giulia 
and since 2018 in the Autonomous Provinces of Trento and 
Bolzano. Affected regions and provinces have also made 
information on TBE vaccination available on websites18-21.  
TBE increase has been shown to be associated with the 
expansion of tick populations resulting from climatic 
factors, increasing abundance of ungulates, and changes in 
human behaviour and land use, in addition to increased 
recognition and reporting of TBE cases22-23. Although the 
distribution of human cases is consistent with that of the 
competent tick vector, the overdispersed distribution of 
ticks in the environment and their very low TBEV prevalence 
(usually below 1%), make them an unsuitable indicator of 
TBEV infection risk. For these reasons, entomological 
studies, even if performed in endemic regions, cannot be 
translated into a direct human risk, and other factors should 
be considered in order to address public health efforts 
toward TBE hazard. For example, since the ‘90s, rising 
cervid population numbers and changes in forest structure 
in the north-eastern regions and provinces of Italy were 
observed in conjuction with an increase in TBE incidence22, 
but this relationship is not always positive and at a 
threshold density level of ungulates TBEV prevalence 
decreases24. Also seroprevalence in domestic animals, 
showed a good spatial correlation with TBE incidence in 
humans and might also uncover presently unknown TBEV 
foci distribution25. 
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Overview of TBE in Italy 
Table 1: Virus, vector, transmission of TBE in Italy (northeastern) 
Viral subtypes, distribution 
European TBEV subtype; north east regions: Friuli-Venezia Giulia, Veneto, Trentino-Alto 
Adige (Figure 3) 
Reservoir animals 
Ticks and small rodents. Consumption of milk and milk products from infected goats, 
sheep, or cows 
Infected tick species (%) Ixodes ricinus 
Dairy product transmission Not documented 
Table 2: TBE-reporting and vaccine prevention in Italy (northeastern) 
Mandatory TBE  
reporting16,6 
Reported by Department of Infectious Diseases, National Institute of Health, Italy in 
collaboration with all the Infectious Diseases Units and Public Health Districts. 
 
Case definition: Clinical criteria are any symptoms of inflammation of the CNS (for 
example, meningitis, meningo-encephalitis, encephalomyelitis, encephaloradiculitis). A 
TBE case is confirmed by at least one of the following five laboratory criteria: TBE specific 
IgM AND IgG antibodies in blood; TBE specific IgM antibodies in CSF; seroconversion or 
four-fold increase of TBE-specific antibodies in paired serum samples; detection of TBE 
viral nucleic acid in a clinical specimen; isolation of TBE virus from clinical specimen. 
 
Surveillance has been enhanced at national level since 2017. 
Special clinical  
features13-15 
Bi-phasic disease is not reported 
At-risk groups are defined by occupational risk (i.e. agricultural workers and forest or 
lumber workers) or risk hobbies (i.e. hiking/trekking, mushroom foraging) 
 
Presumed place of exposure and date of tick bite are recorded 
  
Sequelae (information available on 193 cases): 18.1% with permanent sequelae, and 
28.5% with temporary sequelae 
 
Case-fatality rate: 0.7% 
Available 
vaccines 
TICOVAC 0.5 mL (Pfizer Srl) 
Vaccine  
recommendations and 
reimbursement, and uptake by 
age group/risk group/ general 
population 
Friuli-Venezia Giulia: Vaccination is free of charge for residents. 
 
Veneto: Vaccination is not free of charge. Recommended for those who live in the woods 
or in rural areas at risk for TBE. 
 
Trentino-Alto Adige: Vaccination is free of charge for residents. 
Name, address/website of TBE  
National Reference Center 
Prof. Giovanni Rezza 
Dipartimento Malattie Infettive 
Istituto Superiore di Sanità 
Viale Regina Elena, 299 
00161 Roma, Italia 
 
Website: https://www.iss.it/?p=27 
In conclusion, the incidence of TBE in Italy is relatively low, 
and the risk appears to be geographically restricted to the 
pre-alpine and alpine regions of the country. More studies 
are necessary to disentangle the complex factors that are 
involved in the circulation and maintainance of TBEV in an 
endemic focus and early-warning predictors should be 
better assessed. Human cases are currently reported from 
northeastern regions (Friuli-Venezia Giulia, Veneto and in 
the Provinces of Trento and Bolzano), with the highest 
incidence rates being reported in areas between 400 and 
600 m a.s.l. TBE vaccine (TICOVAC) is offered to resident 
people living in high-risk areas, but its impact on disease 
occurrence in the affected communities is not yet 
evaluated. 
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 Figure 1: Reported human cases of TBE, Italy, 2000-2018. 
Source: http://demo.istat.it/  
*Data on vaccination rate : Appendix—Figure 1 
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 Figure 2: Age and gender distribution of reported human cases of TBE, Italy, 2000-2016. 
Source Data: Appendix—Figure 2 
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Figure 3: Regions in northeastern Italy reporting TBE cases (BZ=Autonomous Province of Bolzano; 
TN=Autonomous Province of Trento; [BZ+TN=Trentino-Alto Adige] VEN= Veneto; FVG= Friuli-Venezia 
Giulia). 
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Vaccination 
rate (%) 
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Appendix 
Age group 
(years) 
Males Females All 
0-9 7 6 13 
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20-29 28 13 41 
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Source data: Figure 1  
Source data: Figure 2 
*Neuro-invasive laboratory confirmed TBEV infections 
TBE in Italy 
Note: Data on vaccine coverage are not available for 2015-2018 
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